Increased expression of COX-2 in recurrent basal cell carcinoma of the skin: A pilot study

Introduction: Basal cell carcinoma (BCC) is the most frequent malignant skin tumor. BCC rarely metastasizes, but it is often locally aggressive. Cyclooxygenase-2 (COX-2) is critical for tumor formation, angiogenesis and metastasis. Matrix metalloproteinases (MMPs) are the members of the family of zi...

Full description

Bibliographic Details
Main Authors: Nermin Karahan, Sirin Baspinar, Kemal Kursat Bozkurt, Eylem Caloglu, Ibrahim Metin Ciris, Nilgun Kapucuoglu
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2011-01-01
Series:Indian Journal of Pathology and Microbiology
Subjects:
Online Access:http://www.ijpmonline.org/article.asp?issn=0377-4929;year=2011;volume=54;issue=3;spage=526;epage=531;aulast=Karahan
_version_ 1828382940008022016
author Nermin Karahan
Sirin Baspinar
Kemal Kursat Bozkurt
Eylem Caloglu
Ibrahim Metin Ciris
Nilgun Kapucuoglu
author_facet Nermin Karahan
Sirin Baspinar
Kemal Kursat Bozkurt
Eylem Caloglu
Ibrahim Metin Ciris
Nilgun Kapucuoglu
author_sort Nermin Karahan
collection DOAJ
description Introduction: Basal cell carcinoma (BCC) is the most frequent malignant skin tumor. BCC rarely metastasizes, but it is often locally aggressive. Cyclooxygenase-2 (COX-2) is critical for tumor formation, angiogenesis and metastasis. Matrix metalloproteinases (MMPs) are the members of the family of zinc (Zn)- and calcium-dependent endopeptidases that degrade the extracellular matrix. Materials and Methods: In our study, we used immunohistochemical methods for the evaluation of COX-2, MMP-2 and MMP-9 expression in tissue samples of 30 primary and 10 recurrent skin BCC cases. Results: Immunohistochemical COX-2 expression was significantly higher in the infiltrating pattern of BCC compared with the nodular (P = 0.005) and superficial (P = 0.041) subtypes in the primary BCC group. There was not a significant difference between nodular and superficial BCCs for COX-2 expression. In addition, COX-2 expression was significantly higher in the recurrent BCC group than in the primary BCC group (P = 0.030). There was no statistically significant difference between the histological subtypes of primary BCCs and between primary and recurrent BCCs for MMP-2 and MMP-9 expressions. Conclusions: Our data confirm previous findings that COX-2 and MMP-9 expressions are increased in BCC. Our results revealed an elevated COX-2 expression in recurrent BCCs. We suggest that COX-2 inhibition might have beneficial effects in BCCs, especially for the tumors with a higher level of COX-2 expression or aggressive phenotype.
first_indexed 2024-12-10T04:41:11Z
format Article
id doaj.art-a758a621cb7a42368633f5ae48887425
institution Directory Open Access Journal
issn 0377-4929
language English
last_indexed 2024-12-10T04:41:11Z
publishDate 2011-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Indian Journal of Pathology and Microbiology
spelling doaj.art-a758a621cb7a42368633f5ae488874252022-12-22T02:01:53ZengWolters Kluwer Medknow PublicationsIndian Journal of Pathology and Microbiology0377-49292011-01-0154352653110.4103/0377-4929.85086Increased expression of COX-2 in recurrent basal cell carcinoma of the skin: A pilot studyNermin KarahanSirin BaspinarKemal Kursat BozkurtEylem CalogluIbrahim Metin CirisNilgun KapucuogluIntroduction: Basal cell carcinoma (BCC) is the most frequent malignant skin tumor. BCC rarely metastasizes, but it is often locally aggressive. Cyclooxygenase-2 (COX-2) is critical for tumor formation, angiogenesis and metastasis. Matrix metalloproteinases (MMPs) are the members of the family of zinc (Zn)- and calcium-dependent endopeptidases that degrade the extracellular matrix. Materials and Methods: In our study, we used immunohistochemical methods for the evaluation of COX-2, MMP-2 and MMP-9 expression in tissue samples of 30 primary and 10 recurrent skin BCC cases. Results: Immunohistochemical COX-2 expression was significantly higher in the infiltrating pattern of BCC compared with the nodular (P = 0.005) and superficial (P = 0.041) subtypes in the primary BCC group. There was not a significant difference between nodular and superficial BCCs for COX-2 expression. In addition, COX-2 expression was significantly higher in the recurrent BCC group than in the primary BCC group (P = 0.030). There was no statistically significant difference between the histological subtypes of primary BCCs and between primary and recurrent BCCs for MMP-2 and MMP-9 expressions. Conclusions: Our data confirm previous findings that COX-2 and MMP-9 expressions are increased in BCC. Our results revealed an elevated COX-2 expression in recurrent BCCs. We suggest that COX-2 inhibition might have beneficial effects in BCCs, especially for the tumors with a higher level of COX-2 expression or aggressive phenotype.http://www.ijpmonline.org/article.asp?issn=0377-4929;year=2011;volume=54;issue=3;spage=526;epage=531;aulast=KarahanBasal cell carcinomaCOX-2MMP-2MMP-9recurrence
spellingShingle Nermin Karahan
Sirin Baspinar
Kemal Kursat Bozkurt
Eylem Caloglu
Ibrahim Metin Ciris
Nilgun Kapucuoglu
Increased expression of COX-2 in recurrent basal cell carcinoma of the skin: A pilot study
Indian Journal of Pathology and Microbiology
Basal cell carcinoma
COX-2
MMP-2
MMP-9
recurrence
title Increased expression of COX-2 in recurrent basal cell carcinoma of the skin: A pilot study
title_full Increased expression of COX-2 in recurrent basal cell carcinoma of the skin: A pilot study
title_fullStr Increased expression of COX-2 in recurrent basal cell carcinoma of the skin: A pilot study
title_full_unstemmed Increased expression of COX-2 in recurrent basal cell carcinoma of the skin: A pilot study
title_short Increased expression of COX-2 in recurrent basal cell carcinoma of the skin: A pilot study
title_sort increased expression of cox 2 in recurrent basal cell carcinoma of the skin a pilot study
topic Basal cell carcinoma
COX-2
MMP-2
MMP-9
recurrence
url http://www.ijpmonline.org/article.asp?issn=0377-4929;year=2011;volume=54;issue=3;spage=526;epage=531;aulast=Karahan
work_keys_str_mv AT nerminkarahan increasedexpressionofcox2inrecurrentbasalcellcarcinomaoftheskinapilotstudy
AT sirinbaspinar increasedexpressionofcox2inrecurrentbasalcellcarcinomaoftheskinapilotstudy
AT kemalkursatbozkurt increasedexpressionofcox2inrecurrentbasalcellcarcinomaoftheskinapilotstudy
AT eylemcaloglu increasedexpressionofcox2inrecurrentbasalcellcarcinomaoftheskinapilotstudy
AT ibrahimmetinciris increasedexpressionofcox2inrecurrentbasalcellcarcinomaoftheskinapilotstudy
AT nilgunkapucuoglu increasedexpressionofcox2inrecurrentbasalcellcarcinomaoftheskinapilotstudy